MA
Mottiwala Aziz
Directeur Commercial
OtherM
内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Mottiwala Aziz, Directeur Commercial. Officer active across 1 company, notably Tarsus Pharmaceuticals, Inc.. In total, 18 disclosures have been published. Split: 0 buy · 12 sells. Total volume traded: €1.5m. Activity tracked since 10 September 2021. The latest transaction was filed on 17 March 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Mottiwala Aziz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
4,286 股@ US$69.4216.6% 占其流量Common StockSEC:0001788542-26-000007:0
26,482 股Common StockSEC:0001788542-26-000005:0
17,500 股@ US$43.7651.7% 占其流量Common StockSEC:0001819790-25-000081:0
3,643 股@ US$46.2918.4% 占其流量Common StockSEC:0001819790-25-000059:0
20,957 股Common StockSEC:0001819790-25-000042:0
12,938 股Common StockSEC:0001819790-24-000047:0
2,400 股@ US$20.055.1% 占其流量Common StockSEC:0001788542-23-000006:0
100 股@ US$20.000.2% 占其流量Common StockSEC:0001209191-23-036395:0
2,143 股@ US$18.614.4% 占其流量Common StockSEC:0001209191-23-035579:0
349 股@ US$12.890.5% 占其流量Common StockSEC:0001788542-23-000004:0
339 股@ US$13.280.5% 占其流量Common StockSEC:0001788542-23-000002:0
4,790 股Common StockSEC:0001209191-23-019879:0
6,857 股@ US$17.7214.0% 占其流量Common StockSEC:0001788542-22-000006:0
4,416 股@ US$10.995.8% 占其流量Common StockSEC:0001788542-22-000004:0
1,889 股@ US$28.113.0% 占其流量Common StockSEC:0001819790-21-000055:0
100 股@ US$28.030.2% 占其流量Common StockSEC:0001819790-21-000047:0
5,458 股@ US$26.7538.1% 占其流量Common StockSEC:0001819790-21-000045:0
4,350 股@ US$10.992.6% 占其流量Common StockSEC:0001819790-21-000031:0
About Mottiwala Aziz
Mottiwala Aziz is Chief Commercial Officer at Tarsus Pharmaceuticals, Inc. The 18 filings in the recent sample available, from 2021-09-14 to 2026-03-19, are all associated with sales totaling EUR 1465737, with the modal transaction nature shown as sale.